
Adam Louis Kenet
About Me
Adam is a second-year MD-PhD student from New York City. He graduated from Johns Hopkins University with a major in Biomedical Engineering (Immunoengineering focus area) and a minor in Computational Medicine. At Johns Hopkins, Adam joined Dr. Anthony Leung’s lab in the Department of Biochemistry and Molecular Biology, where he studied the biophysical properties of poly(ADP-ribose). He worked on projects using experimental and simulated smFRET data to investigate the flexibility of poly(ADP-ribose) polymers and their interactions with proteins. For his senior project, Adam led a team of students applying machine learning to clinical data (i.e., ECG, vital signs, and labs) to develop a risk score to predict cardiac arrest in the pediatric intensive care unit before onset. After graduation, Adam spent two years working in Dr. Grégoire Altan-Bonnet’s lab at the National Cancer Institute of the NIH. There, Adam used computational and experimental methods to model tumor response to CAR-T cells in order to understand tumor relapse behavior. He helped develop a Python package that automatically processes bioluminescent tumor images, quantifies tumor burden, classifies tumor behavior, and parametrizes tumor dynamics. He then applied this pipeline to a large set of pre-clinical experiments (n>1000 mice) conducted to assess the potency of CAR-T cells against leukemia. While in Maryland, Adam also worked as an EMT with the Baltimore County and Montgomery County Fire Departments.
Language
English
Position
GRADUATE STUDENT | Graduate Students
Research Topics
Cancer, Cardiac Arrest and Resuscitation, Computational Biology, Immunology, Mathematical Modeling of Biomedical Systems, Personalized Medicine
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Immunology [IMM]
Education
BS, Johns Hopkins University
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. KENET has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.